Biopreservation: Market Research Report

January 2015 | 256 pages | ID: BAF7AD76EC4EN
Global Industry Analysts, Inc

Abstracts

This report analyzes the worldwide markets for Biopreservation in US$ Million. The Global market is further analyzed by the following Product Segments, Applications, and Biospecimen Type - Product Segments: Equipment, and Media; Applications: R&D, Therapeutic, and Others; Biospecimen Types: Organs, Stem Cells, Tissues, and Others. The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, Latin America, and Rest of World. Annual estimates and forecasts are provided for the period 2013 through 2020. Market data and analytics are derived from primary and secondary research. Company profiles are primarily based on public domain information including company URLs. The report profiles 82 companies including many key and niche players such as -

• Atlanta Biologicals, Inc.
• Biocision LLC
• Biogenics Inc.
• Biolife Solutions, Inc.
• Cell & Tissue Systems, Inc.

Contents

I. INTRODUCTION, METHODOLOGY & PRODUCT DEFINITIONS

Study Reliability and Reporting Limitations
Disclaimers
Data Interpretation & Reporting Level
Quantitative Techniques & Analytics
Product Definition and Scope of Study

II. EXECUTIVE SUMMARY

1. INDUSTRY OVERVIEW

Biopreservation - A Critical Activity for Improving Human Healthcare
Rapidly Mushrooming Biorepositories Portend Bright Outlook for Market Growth
Western Countries Dominate, Developing Economies to Lend Growth Momentum
R&D and Therapeutic Applications Corner Bulk of Demand
Competitive Scenario
Biopreservation Market Remains Highly Competitive

Table 1. Global Biopreservation Equipment Market by Leading Players (2014): Percentage Market Share Breakdown of Dollar Revenues for Biogenics, BioCision, Cesca Therapeutics, Custom Biogenic Systems, Princeton Cryotech, So-Low Environmental Equipment, Taylor-Wharton Cryogenics, Thermo Fisher Scientific, VWR International, and Others (includes corresponding Graph/Chart)

Custodiol HTK Gains Prominence vs. the Gold Standard UW Solution

2. MAJOR GROWTH DRIVERS & MARKET TRENDS

Improving Healthcare Expenditure Propels Demand

Table 2. Per-Capita Healthcare Expenditure in Select Regions (2013) (includes corresponding Graph/Chart)

Table 3. Healthcare Spending as a Percentage of GDP in Select Countries (2013) (includes corresponding Graph/Chart)

Development of Regenerative Medicine Accelerates Demand for Improved Biopreservation Solutions

Table 4. Global Regenerative Medicines Market by Category (2015E): Percentage Breakdown for Biopharmaceuticals, Cell and Tissue-Based Therapies, and Regenerative Devices & Compounds (includes corresponding Graph/Chart)

Growing Prevalence of Chronic Diseases Highlights Importance of Maintaining Demographic and Age based Databases
Key Disease Statistics – Opportunity Indicators

Table 5. Worldwide Incidence of Cancer (2012, 2020 & 2030): Number of New Cases Diagnosed (includes corresponding Graph/Chart)

Table 6. World Cancer Incidence by Geographic Region and Gender (2012): Number of New Cancer Cases Reported (in Thousands) for Asia-Oceania, Europe, North America, Latin America & the Caribbean, and Africa (includes corresponding Graph/Chart)

Table 7. Fatalities by Heart Conditions - Estimated Percentage Breakdown for Cardiovascular Disease, Ischemic Heart Disease, Stroke, and Others (includes corresponding Graph/Chart)

Table 8. Global Annual Medical Cost of CVD in US$ Billion (2010-2030) (includes corresponding Graph/Chart)

Table 9. Global Cost of Respiratory Therapy by Disease (2015): Percentage Breakdown of Therapy Costs for Asthma, Chronic Obstructive Pulmonary Disease (COPD), Idiopathic Pulmonary Fibrosis, and Others (includes corresponding Graph/Chart)

Biopreservation Media Play Pivotal role in Biomarker Exploration and Development of Companion Diagnostics
Advancements in Personalized Medicine - A Megatrend Catalyzing Growth
Growing Awareness of Stem Cell Therapy Propels Market Forward, Stem Cell Research in Top Gear

Table 10. Global Stem Cell Usage in Research (2013): Percentage Share Breakdown by Type (includes corresponding Graph/Chart)

Advancements in Organ and Tissue Banking Critical for Meeting Huge Unmet Demand for Transplantations
Continuous Hypothermic Perfusion/Hypothermic Perfusion Preservation
New Paradigms in Heart and Lung Preservation
Several Challenges Remain to be Addressed for Cryopreservation of Complex Tissues
Major Strides Achieved in HBS Sample Tracking Technologies
LIMS Suites Integrated with Sample Tracking Modules
RFID Tags - Ideal for Cryogenic Applications
MEMS-Based Tracking Tags Take Biosample Tagging to the Next Level
Need for Harmonization and Networking of Biobanks, Supplemented by Biolibraries and Virtual Biobanks
Commercial Biobanks Slowly Gain Acceptance
Growing Diversity of HBS Increases Spatial Constraints of Biorepositories
Dearth of Standardized and Quality Biospecimens Pose Problems
Mounting Costs and Funding Cutbacks Undermine Viability of Biopreservation
Dried Blood Spots at Room Temperature – A Potential Alternative for Cryogenic Preservation
Donor Engagement and Support - Key to Resolving Ethical and Regulatory Hurdles for Biorepositories
Biorepositories Increasingly Adopt Automation to Boost Productivity
Dry Storage Vessels to Unseat Ultra-low Freezers
Cold Chain Systems - An Overlooked, Albeit Important Aspect of Biopreservation

3. PRODUCT OVERVIEW

Biopreservation
Biopreservation Equipment
Biopreservation Media
Types of Biopreserved Biospecimens
Applications of Biopreservation Equipment and Media
Therapeutic Applications
Research Applications
Other Applications

4. PRODUCT INTRODUCTIONS

BioLife Solutions Introduces BloodStor 27 NaCl Cryopreservation Media
BioCision Submits MAF for ThawSTAR Automated Cell Thawing System to USFDA
BioCision Releases CryoPod Carrier
BioLife Solutions Unveils New Packages for BloodStor and CryoStor Cryopreservation Media
BioCision Launches ThawSTAR Automated Sample Thawing System
BioCision LLC Introduces BioT Temperature Stability Systems
Panasonic Debuts New Biomedical Freezer Line for -30?C Storage

5. RECENT INDUSTRY ACTIVITY

Asterand Bioscience Takes Over AdeptBio
Roche Acquires Signature Diagnostics
Cyprus, The University of Cyprus to Purchase Biobank
Monash University Commences Biorepository in Alfred Medical Research & Education Precinct
LabConnect Shifts Operations Center to New Facility
Cardio3 BioSciences Adopts BioLife CryoStor Cryopreservation Media for CHART Clinical Trials
Cord Blood Registry Selects BioLife’s CryoStor Media for Umbilical Cord Stem Cell Storage
Mayo Clinic Selects BioLife CryoStor Cell Freeze Media for Pediatric CHD Study
BioCision to Collaborate with Celgene Cellular Therapeutics for Developing ThawSTAR
TxCell Selects BioCision’s Temperature Standardization Products for Ovasave Phase IIb Clinical Trial
Brooks Automation Invests into, Collaborates with BioCision
Adaptimmune Adopts BioLife Solutions’ CryoStor Cell Freeze Media for Phase I/II, Cell-Based Cancer Therapy
BioLife Solutions, SAVSU Technologies Forms Joint Venture Company, biologistex CCM
Parcell Laboratories Selects BioLife Solutions’ CryoStor Media for ELA Stem Cell Studies
RoosterBio Selects BioLife Solutions’ CryoStor Cryopreservation Media for Commercializing hMSC Products
Cesca Therapeutics Secures Contract from Upstate Cord Blood Bank
SeraCare Life Sciences Divests Biorepository Business to Precision Health Holdings
Mayo Clinic Establishes Biobank in Arizona for Population-wide Study
Department of Veterans Affairs Commences Gulf War Veterans’ Illnesses Biorepository
Apollo JV with Saarum Innovations Sets Up First-ever Commercial Biobank in India
AstraZeneca Establishes Biobank and Clinical Research Center in Russia
BioCision Announces Collaboration with ATCC
China National Genebank Partners with BioStorage Technologies
DaVita Labs and Myriad RBM Collaborate for Renal Disease Studies
Laboratory Corporation of America Secures CAP Accreditation for LabCorp Biorepository
AMSBIO Expands Biorepository and Collection Services
Cell Therapy Catapult, Roslin Cells to Set Up Pluripotent Stem Cells Biobank

6. FOCUS ON SELECT PLAYERS

Atlanta Biologicals, Inc. (USA)
Biocision LLC (USA)
Biogenics Inc. (USA)
Biolife Solutions, Inc. (USA)
Cell & Tissue Systems, Inc. (USA)
Cesca Therapeutics Inc. (USA)
Core Dynamics, Ltd. (Israel)
Custom Biogenic Systems, Inc. (USA)
Essential Pharmaceuticals LLC (USA)
Lifeline Scientific, Inc. (USA)
Panasonic Biomedical Sales Europe B. V. (The Netherlands)
Preservation Solution, Inc. (USA)
Princeton Cryotech, Inc. (USA)
Sigma-Aldrich Corporation (USA)
So-Low Environmental Equipment Co., Inc. (USA)
Taylor-Wharton Cryogenics LLC (USA)
Thermo Fisher Scientific, Inc. (USA)
VWR International LLC (USA)
Wak-Chemie Medical Gmbh (Germany)

7. GLOBAL MARKET PERSPECTIVE

Table 11. World Recent Past, Current & Future Analysis for Biopreservation Equipment and Media by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific, Latin America, and Rest of World Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2013 through 2020 (includes corresponding Graph/Chart)

Table 12. World 8-Year Perspective for Biopreservation Equipment and Media by Geographic Region - Percentage Share Breakdown of Dollar Revenues for US, Canada, Japan, Europe, Asia-Pacific, Latin America, and Rest of World Markets for Years 2013, 2015 and 2020 (includes corresponding Graph/Chart)

Table 13. World Recent Past, Current & Future Analysis for Biopreservation Equipment and Media by Product Segment - Equipment and Media Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2013 through 2020 (includes corresponding Graph/Chart)

Table 14. World 8-Year Perspective for Biopreservation Equipment and Media by Product Segment - Percentage Share Breakdown of Dollar Revenues for Equipment and Media Markets for Years 2013, 2015 and 2020 (includes corresponding Graph/Chart)

Table 15. World Recent Past, Current & Future Analysis for Biopreservation Equipment and Media by Application - R&D, Therapeutic, and Others Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2013 through 2020 (includes corresponding Graph/Chart)

Table 16. World 8-Year Perspective for Biopreservation Equipment and Media by Application - Percentage Share Breakdown of Dollar Revenues for R&D, Therapeutic, and Others Markets for Years 2013, 2015 and 2020 (includes corresponding Graph/Chart)

Table 17. World Recent Past, Current & Future Analysis for Biopreservation Equipment and Media by Biospecimen Type - Organs, Stem Cells, Tissues, and Others Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2013 through 2020 (includes corresponding Graph/Chart)

Table 18. World 8-Year Perspective for Biopreservation Equipment and Media by Biospecimen Type - Percentage Share Breakdown of Dollar Revenues for Organs, Stem Cells, Tissues, and Others Markets for Years 2013, 2015 and 2020 (includes corresponding Graph/Chart)

III. MARKET

1. THE UNITED STATES

A. Market Analysis
United States: The Single Largest Market for Biopreservation
Innovative Biopreservation Approaches Critical for Transplantation Research

Table 19. Waiting List of Patients for Organ Transplants by Organ Type: As of August 2014 (includes corresponding Graph/Chart)

Table 20. The US Kidney Transplants by Donor Type - Deceased and Living: Number of Procedures for 2013, 2014, and 2015 (As of Sept, 2015) (includes corresponding Graph/Chart)

Robust Demand for Regenerative Medicines Augurs Well for Biopreservation solutions Market
Aging Population, Rising Incidence of Chronic Diseases Fuel Demand for Biobanking

Table 21. North American Aging Population by Age Group: 1975-2050 (includes corresponding Graph/Chart)

Table 22. CVD in the US: Cardiovascular Disease Prevalence in Adults by Gender & Age Group (includes corresponding Graph/Chart)

Table 23. New Cancer Cases in Males in US by Body Site (2014) (includes corresponding Graph/Chart)

Table 24. New Cancer Cases in Females in US by Body Site (2014) (includes corresponding Graph/Chart)

Product Introductions
Strategic Corporate Developments
Select Key Players
B. Market Analytics

Table 25. The US Recent Past, Current & Future Analysis for Biopreservation Equipment and Media with Annual Revenue Figures in US$ Million for Years 2013 through 2020 (includes corresponding Graph/Chart)

2. CANADA

A. Market Analysis
Current and Future Analysis
Canada Emerges as a Significant Player in the Field of Regenerative Medicine
Canadians More Receptive to Organ Transplants

Table 26. Canadian Patients on Active Waiting List for Organ Transplants by Type: 2012 (includes corresponding Graph/Chart)

B. Market Analytics

Table 27. Canadian Recent Past, Current & Future Analysis for Biopreservation Equipment and Media with Annual Revenue Figures in US$ Million for Years 2013 through 2020 (includes corresponding Graph/Chart)

3. JAPAN

A. Market Analysis
Current and Future Analysis
Urgent Need for Regenerative Therapeutics in Geriatric Healthcare and Cancer Care to Drive Demand for Biopreservation Media

Table 28. Japanese Elderly (65+ Years) Population: 2000-2020 (includes corresponding Graph/Chart)

Table 29. Cancer Related Deaths by Age Group in Japan (2013) (includes corresponding Graph/Chart)

B. Market Analytics

Table 30. Japanese Recent Past, Current & Future Analysis for Biopreservation Equipment and Media with Annual Revenue Figures in US$ Million for Years 2013 through 2020 (includes corresponding Graph/Chart)

4. EUROPE

A. Market Analysis
Current and Future Analysis
Ageing Population to Drive Demand for Regenerative Medicines

Table 31. European Aging Population by Age Group: 1975-2050 (includes corresponding Graph/Chart)

Table 32. European Country-wise Statistics of 60+ Population as % of Total Population: 2013 (includes corresponding Graph/Chart)

Increasing Organ Transplantations Drive the Need for Preservation

Table 33. European Deceased Organ Donation Rates Per Million Population (PMP) by Country for 2011, 2012 & 2013 (includes corresponding Graph/Chart)

Table 34. European Living Organ Donation Rates Per Million Population (PMP) by Country for 2013 (includes corresponding Graph/Chart)

Table 35. European Single Organ Transplantations by Select Country and Organ Type: 2013

Table 36. European Multi-Organ Transplantations by Select Country and Transplant Type: 2013

Cancer in Europe: Key Statistics

Table 37. Number of New Cancer Cases in Europe: 2012-2030 (includes corresponding Graph/Chart)

B. Market Analytics

Table 38. European Recent Past, Current & Future Analysis for Biopreservation Equipment and Media by Geographic Region - France, Germany, Italy, UK, Spain, Russia, The Netherlands, and Rest of Europe Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2013 through 2020 (includes corresponding Graph/Chart)

Table 39. European 8-Year Perspective for Biopreservation Equipment and Media by Geographic Region - Percentage Share Breakdown of Dollar Revenues for France, Germany, Italy, UK, Spain, Russia, The Netherlands, and Rest of Europe Markets for Years 2013, 2015 and 2020 (includes corresponding Graph/Chart)

4A. FRANCE

Market Analysis

Table 40. French Recent Past, Current & Future Analysis for Biopreservation Equipment and Media with Annual Revenue Figures in US$ Million for Years 2013 through 2020 (includes corresponding Graph/Chart)

4B. GERMANY

A. Market Analysis
Current and Future Analysis
Germany Holds Strong Position in European Regenerative Medicine Sector
Strategic Corporate Development
Wak-Chemie Medical Gmbh – A Key German Player
B. Market Analytics

Table 41. German Recent Past, Current & Future Analysis for Biopreservation Equipment and Media with Annual Revenue Figures in US$ Million for Years 2013 through 2020 (includes corresponding Graph/Chart)

4C. ITALY

A. Market Analysis
Current and Future Analysis
B. Market Analytics

Table 42. Italian Recent Past, Current & Future Analysis for Biopreservation Equipment and Media with Annual Revenue Figures in US$ Million for Years 2013 through 2020 (includes corresponding Graph/Chart)

4D. THE UNITED KINGDOM

A. Market Analysis
Current and Future Analysis
NHS Initiatives for Promulgating Organ Translation Ramp up Usage of Organ Preservation Solutions

Table 43. The UK Organ Donors by Type: May 2015 & May 2014 (includes corresponding Graph/Chart)

Table 44. The UK Organ Transplantation by Type: 2014 Vs. 2015 (includes corresponding Graph/Chart)

Strategic Corporate Development
B. Market Analytics

Table 45. UK Recent Past, Current & Future Analysis for Biopreservation Equipment and Media with Annual Revenue Figures in US$ Million for Years 2013 through 2020 (includes corresponding Graph/Chart)

4E. SPAIN

A. Market Analysis
Current and Future Analysis
B. Market Analytics

Table 46. Spanish Recent Past, Current & Future Analysis for Biopreservation Equipment and Media with Annual Revenue Figures in US$ Million for Years 2013 through 2020 (includes corresponding Graph/Chart)

4F. RUSSIA

A. Market Analysis
Current and Future Analysis
Strategic Corporate Development
B. Market Analytics

Table 47. Russian Recent Past, Current & Future Analysis for Biopreservation Equipment and Media with Annual Revenue Figures in US$ Million for Years 2013 through 2020 (includes corresponding Graph/Chart)

4G. THE NETHERLANDS

A. Market Analysis
Current and Future Analysis
Panasonic Biomedical Sales Europe B. V. – A Key Dutch Player
B. Market Analytics

Table 48. The Netherlands Recent Past, Current & Future Analysis for Biopreservation Equipment and Media with Annual Revenue Figures in US$ Million for Years 2013 through 2020 (includes corresponding Graph/Chart)

4H. REST OF EUROPE

A. Market Analysis
Current and Future Analysis
B. Market Analytics

Table 49. Rest of Europe Recent Past, Current & Future Analysis for Biopreservation Equipment and Media with Annual Revenue Figures in US$ Million for Years 2013 through 2020 (includes corresponding Graph/Chart)

5. ASIA-PACIFIC

A. Market Analysis
Current and Future Analysis
India & China Offer Significant Growth Opportunities

Table 50. Population Statistics in Select Asian Countries & Percentage of Population Aged Above 65 Years (includes corresponding Graph/Chart)

Organ Transplantation Statistics

Table 51. Asia-Pacific Deceased Organ Donor Per Million Population (PMP) by Country for 2011, 2012 & 2013 (includes corresponding Graph/Chart)

Table 52. Asia-Pacific Living Organ Donor Per Million Population (PMP) by Country for 2011, 2012 & 2013 (includes corresponding Graph/Chart)

B. Market Analytics

Table 53. Asia-Pacific Recent Past, Current & Future Analysis for Biopreservation Equipment and Media by Geographic Region - China, India, and Rest of Asia-Pacific Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2013 through 2020 (includes corresponding Graph/Chart)

Table 54. Asia-Pacific 8-Year Perspective for Biopreservation Equipment and Media by Geographic Region - Percentage Share Breakdown of Dollar Revenues for China, India, and Rest of Asia-Pacific Markets for Years 2013, 2015 and 2020 (includes corresponding Graph/Chart)

5A. CHINA

A. Market Analysis
Current and Future Analysis
Government Support to Bolster Growth of Regenerative Medicines Market
Organ Transplantations in China: Years 2010 to 2013 in Review
Transplantation Tourism in China
Strategic Corporate Development
B. Market Analytics

Table 55. Chinese Recent Past, Current & Future Analysis for Biopreservation Equipment and Media with Annual Revenue Figures in US$ Million for Years 2013 through 2020 (includes corresponding Graph/Chart)

5B. INDIA

A. Market Analysis
Current and Future Analysis
Stem Cell Therapy Market Poised for Robust Growth
Low Organ Transplantation Expenses Boost Medical Tourism
Strategic Corporate Development
B. Market Analytics

Table 56. Indian Recent Past, Current & Future Analysis for Biopreservation Equipment and Media with Annual Revenue Figures in US$ Million for Years 2013 through 2020 (includes corresponding Graph/Chart)

5C. REST OF ASIA-PACIFIC

A. Market Analysis
Current and Future Analysis
Australia

Table 57. Australia Organ Transplantations by Organ Type: 2015 (includes corresponding Graph/Chart)

Table 58. Australian Organ Transplants by State: 2015 (includes corresponding Graph/Chart)

Strategic Corporate Development
B. Market Analytics

Table 59. Rest of Asia-Pacific Recent Past, Current & Future Analysis for Biopreservation Equipment and Media with Annual Revenue Figures in US$ Million for Years 2013 through 2020 (includes corresponding Graph/Chart)

6. LATIN AMERICA

A. Market Analysis
Current and Future Analysis
B. Market Analytics

Table 60. Latin America Recent Past, Current & Future Analysis for Biopreservation Equipment and Media by Geographic Region - Brazil, and Rest of Latin America Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2013 through 2020 (includes corresponding Graph/Chart)

Table 61. Latin America 8-Year Perspective for Biopreservation Equipment and Media by Geographic Region - Percentage Share Breakdown of Dollar Revenues for Brazil, and Rest of Latin America Markets for Years 2013, 2015 and 2020 (includes corresponding Graph/Chart)

6A. BRAZIL

A. Market Analysis
Current and Future Analysis
Despite Challenges, Brazilian Regenerative Medicine Sector Holds Promise
A Major Organ Transplant Market
B. Market Analytics

Table 62. Brazilian Recent Past, Current & Future Analysis for Biopreservation Equipment and Media with Annual Revenue Figures in US$ Million for Years 2013 through 2020 (includes corresponding Graph/Chart)

6B. REST OF LATIN-AMERICA

A. Market Analysis
Current and Future Analysis
B. Market Analytics

Table 63. Rest of Latin-America Recent Past, Current & Future Analysis for Biopreservation Equipment and Media with Annual Revenue Figures in US$ Million for Years 2013 through 2020 (includes corresponding Graph/Chart)

7. REST OF WORLD

A. Market Analysis
Current and Future Analysis
Israel Stem Cell Research in Full Swing
Kuwait – A Rapidly Emerging ‘Third World’ Country in Organ Transplants
Strategic Corporate Development
Core Dynamics, Ltd. – A Key Israeli Player
B. Market Analytics

Table 64. Rest of World Recent Past, Current & Future Analysis for Biopreservation Equipment and Media with Annual Revenue Figures in US$ Million for Years 2013 through 2020 (includes corresponding Graph/Chart)

IV. COMPETITIVE LANDSCAPE

Total Companies Profiled:
The United States (50)
Canada (1)
Japan (1)
Europe (24)
  France (2)
  Germany (7)
  The United Kingdom (7)
  Italy (1)
  Rest of Europe (7)
Asia-Pacific (Excluding Japan) (4)
Middle East (2)

About

Once limited to supplying tissues to academics for basic scientific research, biobanking has evolved into a lucrative and complex industry. Increasing use of samples and data in the drug discovery and development process, increased investment in regenerative medicine and the growing trend of preserving stem cells for future use has driven rapid growth in the global biobanking industry. However, the heterogeneity in biobanking regulations and practices regarding collection, storage and consent procedure limits international transfer of samples and data, impeding market growth.

Despite the aforementioned barriers to market growth, growing investment in regenerative medicine from the private and public sectors points towards an optimistic future for the biobanking industry, particularly for private (family) cord blood banking and stem cell biobanking. Although stem cell biobanking is in its nascent phase, the market is expected to grow significantly, driven mainly by clinical studies on stem cell therapy. The growing use of stem cells derived from adipose tissue and umbilical cord blood in ongoing and planned clinical studies suggests that they may overtake bone marrow-derived stem cells in the near future.